Agreement and Plan of ReorganizationAgreement and Plan of Reorganization • September 24th, 2021 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
This Agreement and Plan of Reorganization (this “Agreement”), dated as of September 10, 2021, is entered into among InMed Pharmaceuticals Inc., a British Columbia, Canada corporation (“Parent”), InMed LLC, a Delaware limited liability company and indirect wholly owned subsidiary of Parent (“Merger Sub”), BayMedica, Inc., a Nevada corporation (“Company”), BM REP, LLC, a Nevada limited liability company, solely in its capacity as Stockholder Representative (“Stockholder Representative”), Philip J. Barr, The Shane A. Johnson Trust DTD April 18, 1997, as amended, Shane A. Johnson TTEE, Shane A. Johnson, Charles K. Marlowe, and the other Stockholders listed on the signature pages hereto.
FORM OF SERIES A COMMON SHARES PURCHASE WARRANT INMED PHARMACEUTICALS INC.Warrant Agreement • September 24th, 2021 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
THIS SERIES A COMMON SHARES PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) ____________2 (the “Termination Date”) but not thereafter, to subscribe for and purchase from InMed Pharmaceuticals Inc., a company incorporated under the laws of the Province of British Columbia (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of common shares of the Company (the “Common Shares”). The purchase price of one share of Common Shares under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
INDEMNITY AGREEMENTIndemnification Agreement • September 24th, 2021 • InMed Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
INMED PHARMACEUTICALS INC., a British Columbia company having a principal place of business at Suite 310 – 815 West Hastings St., Vancouver, British Columbia, V6C 1B4, Canada
